AKT1 and acute myeloid leukemia: Numerous studies have reported that the PI3K/AKT/mTOR signaling pathway is constitutively activated in leukemia cells20,21, and hyperactivation of the PI3K/AKT pathway has been associated with drug resistance and relapse in AML cells5.